So we have not changed for the last 40, 000 plus years, [00:11:00] how to expect that I'm different than my sister, or I'm different than my girlfriend, or whatever, right
Fukumoto, T
Importantly, these trials exhibited a high degree of heterogeneity in terms of the types of substances studied, patient characteristics, and treatment protocols, which posed significant challenges to drawing definitive conclusions
Recent Phase 2 clinical data from the BMT-801 study demonstrated that PT-141 co-administered with the GLP-1/GIP agonist tirzepatide produces synergistic effects on weight loss
Does my plan have the $200/month Evernorth cost cap for GLP-1s
Phone support at (888) 266-5071 is available during business hours (8am-8pm) for billing and technical questions only